Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,090 public trials 2,046 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Study of Lymphoma in Asia

NCT01584141

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations
  • Tianjin Medical University Cancer Institute & Hospital Hexi District, China
  • West China Hospital of Sichuan University Sichuan, China
  • Queen Mary Hospital Sai Ying Pun, Hong Kong
  • Buddhis Dalin Tzu Chi General Hospital Dalin Town, Taiwan
View Trial Details
Completed

Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas

NCT02900716

Conditions
B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +18 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma

NCT00341952

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Southern California Los Angeles, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • Wayne State University Hutzel Hospital Detroit, Michigan, United States
  • University of Washington Seattle, Washington, United States
View Trial Details
Completed

Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma

NCT02581878

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Skanes Universitetssjukhus Lund, Sweden
  • Southampton General Hospital Southampton, Hampshire, United Kingdom
  • Royal Marsden NHS Trust (Surrey) Sutton, Surrey, United Kingdom
  • Royal Free Hospital London, United Kingdom
View Trial Details
Completed

IACS-010759 in Advanced Cancers

NCT03291938

Conditions
Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +46 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma

NCT02831686

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Memoral Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

NCT02580552

Conditions
Adult T-Cell Leukemia/Lymphoma (ATLL), Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +29 more
Locations
  • City of Hope Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Center at University of California, Irvine Orange, California, United States
View all 19 locations
View Trial Details
Completed

Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

NCT02228096

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations
  • Childrens Hospital Los Angeles SC Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Children's Healthcare of Atlanta SC-2 Atlanta, Georgia, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 13 locations
View Trial Details

Related conditions